Documentos relacionados

1. Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia.
2. RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia.
3. The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia.
4. Asymmetric Hairpins DNA Encapsulated Silver Nanoclusters for In Situ Fluorescence Imaging of Fusion Gene Isoforms in Bone Marrow.
5. The vascular bone marrow niche influences outcome in chronic myeloid leukemia <i>via</i> the E-selectin - SCL/TAL1 - CD44 axis.
6. CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected <i>BCR/ABL</i> Leukemic Cells in CML.
7. The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia.
8. Synthetic Reprogramming of Kinases Expands Cellular Activities of Proteins.
9. Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
10. Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients.